PAD, AAA: High Lp(a) Portends Problems Beyond CVD
While the field awaits targeted therapies, estimates of absolute 10-year risks can be used to counsel patients, researchers say.
Source: tctmd.com
Page 4 - Herlev News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Herlev. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Herlev Today - Breaking & Trending Today
Patients With Psoriasis Lose Weight With Roflumilast: Study
Oral roflumilast not only appears to improve skin symptoms, but it could also help with weight loss, results of the phase 2 PSORRO study suggest.
Source: medscape.com
The 2022 VC crash, in 4 charts
Rolling one-year VC fund returns fell to -17% in 2022, while VC fundraising is on track to hit a 6-year low by the end of the year.
Source: fortune.com
New corona research could improve vaccination techniques
New research from Copenhagen University Hospital – Rigshospitalet and Herlev and Gentofte Hospital has shed new light on the immune system’s complex struggle against the coronavirus.
Source: healthcare-in-europe.com
The potential benefits of ribavirin and pleconaril treatment on type 1 diabetes
Researchers investigate whether ribavirin and pleconaril could stimulate endogenous insulin production among individuals with incident type 1 diabetes.
Source: news-medical.net